Food Allergy News

The field of food allergy treatment has been evolving rapidly, with several promising developments in recent years. Typically, much of what makes headlines, though, surrounds who pays for the headlines.

DBV Technologies recently provided updates on its Viaskin Peanut Program for children and toddlers, announcing recruitment for the VITESSE study and progress in the COMFORT Toddlers supplemental safety study.

SAN ANTONIO — How good are home allergy tests? Should patients pause biologic treatment before oral food challenges? Is it possible to stop pediatricians from ordering so many food panels? Is skin prick testing needed before OFCs?

Peanut and egg were found to be new triggers for food protein-induced enterocolitis syndrome, and milk and oat surpassed rice as the most common triggers, according to a study in The Journal of Allergy and Clinical Immunology: In Practice.

SAN ANTONIO — Preparation is key to successful oral food challenges, said Maria Crain, APRN, CPNP-PC, AE-C, pediatric nurse practitioner, University of Texas Southwestern Medical Center Food Allergy Center.

A recent study published in the European Journal of Allergy and Clinical Immunology shows that significant cross-reactivity may exist between lupin and other legumes.

A novel peptide that uniquely affects the effector and regulatory arms of immune responses has potential for treating eosinophilic esophagitis and other allergic diseases, according to a press release from Revolo Biotherapeutics.

A clinical decision support tool prompted pediatric providers to ask families about introducing peanuts into their infants’ diets during well child visits, according to a study published in The Journal of Allergy & Clinical Immunology.

Healio has compiled July’s most-read news in asthma and allergy.

The FDA has approved Palforzia for children aged 1 to 3 years who have a peanut allergy that has been diagnosed by a physician, according to a press release from its manufacturer, Stallergenes Greer.